Literature DB >> 8319335

Enhanced revascularization of the ischemic limb by angiogenic therapy.

L Q Pu1, A D Sniderman, R Brassard, K J Lachapelle, A M Graham, R Lisbona, J F Symes.   

Abstract

BACKGROUND: This study tests the efficacy of an angiogenic growth factor, endothelial cell growth factor, in a rabbit model of persistent hindlimb ischemia. METHODS AND
RESULTS: Ischemia was induced in the left hindlimb of 22 New Zealand White rabbits by ligation of the distal external iliac artery and complete excision of the common and superficial femoral arteries. Two groups of animals were studied: Group 1 consisted of 11 animals who for 10 days received daily intramuscular injections of 4 mg of endothelial cell growth factor beginning on postoperative day 11, and group 2 consisted of 11 animals who underwent the same surgical ischemic procedure but received only injections of saline daily for the same postoperative period. Perfusion of the ischemic left limb was compared with the normal right limb in each animal on postoperative days 10, 20, 30, and 40 using the calf blood pressure ratio, 99mTc macroaggregate radioisotopic perfusion scans, and serial angiography. Neovascularization in the left thigh at day 40 was quantified from the angiograms. Each technique documented that animals in group 1 had significantly better perfusion than animals in group 2; that is, the calf pressure ratio was higher in group 1 than in group 2 (0.56 versus 0.32 at day 20, 0.64 versus 0.44 at day 30, and 0.70 versus 0.50, P < .0001), and the calf radioisotopic perfusion ratio was also higher in group 1 than in group 2 (0.88 versus 0.74 at day 20, P < .02; 0.93 versus 0.76 at day 30, and 0.96 versus 0.79 at day 40, P < .008). Angiographic studies correlated well with these results demonstrating much earlier distal arterial reconstitution and enhanced neovascularization (23.8 versus 9.0 vessels, P < .007).
CONCLUSIONS: The data clearly indicate that an angiogenic growth factor, endothelial cell growth factor, promotes revascularization in this experimental ischemic hindlimb model, raising the possibility that in the future such agents might be of value in humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319335     DOI: 10.1161/01.cir.88.1.208

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Current clinical perspectives on myocardial angiogenesis.

Authors:  Debabrata Mukherjee
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 2.  In vitro models of angiogenesis.

Authors:  Areck A Ucuzian; Howard P Greisler
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

Review 3.  Angiogenesis and vasculogenesis in treatment of cardiovascular disease.

Authors:  A Rivard; J M Isner
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

Review 4.  Tissue Engineering of the Microvasculature.

Authors:  Joe Tien
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

5.  Reversible thermal denaturation of human FGF-1 induced by low concentrations of guanidine hydrochloride.

Authors:  S I Blaber; J F Culajay; A Khurana; M Blaber
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

Review 6.  Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions.

Authors:  C Emanueli; P Madeddu
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

7.  Platelet-derived growth factor BB induces functional vascular anastomoses in vivo.

Authors:  D M Brown; S P Hong; C L Farrell; G F Pierce; R K Khouri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

8.  A novel regulator of angiogenesis in endothelial cells: 5-hydroxytriptamine 4 receptor.

Authors:  Jasmina Profirovic; Elena Strekalova; Norifumi Urao; Aleksandar Krbanjevic; Alexandra V Andreeva; Sudhahar Varadarajan; Tohru Fukai; René Hen; Masuko Ushio-Fukai; Tatyana A Voyno-Yasenetskaya
Journal:  Angiogenesis       Date:  2012-08-18       Impact factor: 9.596

9.  X-ray structure and biophysical properties of rabbit fibroblast growth factor 1.

Authors:  Jihun Lee; Sachiko I Blaber; Andre Irsigler; Eric Aspinwall; Michael Blaber
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-30

Review 10.  Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.

Authors:  E J Battegay
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.